AU5835494A - Use of idazoxan and its derivatives in the treatment of alzheimer-type senility - Google Patents

Use of idazoxan and its derivatives in the treatment of alzheimer-type senility

Info

Publication number
AU5835494A
AU5835494A AU58354/94A AU5835494A AU5835494A AU 5835494 A AU5835494 A AU 5835494A AU 58354/94 A AU58354/94 A AU 58354/94A AU 5835494 A AU5835494 A AU 5835494A AU 5835494 A AU5835494 A AU 5835494A
Authority
AU
Australia
Prior art keywords
idazoxan
senility
alzheimer
derivatives
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU58354/94A
Other versions
AU680463B2 (en
Inventor
Francis Colpaert
Thierry Imbert
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pierre Fabre Medicament SA
Original Assignee
Pierre Fabre Medicament SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pierre Fabre Medicament SA filed Critical Pierre Fabre Medicament SA
Publication of AU5835494A publication Critical patent/AU5835494A/en
Application granted granted Critical
Publication of AU680463B2 publication Critical patent/AU680463B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU58354/94A 1993-01-07 1994-01-06 Use of idazoxan and its derivatives in the treatment of alzheimer-type senility Expired - Fee Related AU680463B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9300084A FR2700113B1 (en) 1993-01-07 1993-01-07 Use of Idazoxan and its derivatives for the manufacture of medicaments intended for the treatment of neurodegenerative diseases and in particular the evolution of Alzheimer's disease.
FR9300084 1993-01-07
PCT/FR1994/000014 WO1994015603A1 (en) 1993-01-07 1994-01-06 Use of idazoxan and its derivatives in the treatment of alzheimer-type senility

Publications (2)

Publication Number Publication Date
AU5835494A true AU5835494A (en) 1994-08-15
AU680463B2 AU680463B2 (en) 1997-07-31

Family

ID=9442871

Family Applications (1)

Application Number Title Priority Date Filing Date
AU58354/94A Expired - Fee Related AU680463B2 (en) 1993-01-07 1994-01-06 Use of idazoxan and its derivatives in the treatment of alzheimer-type senility

Country Status (8)

Country Link
EP (1) EP0678024A1 (en)
JP (1) JPH08505154A (en)
AU (1) AU680463B2 (en)
CA (1) CA2153399A1 (en)
FR (1) FR2700113B1 (en)
NZ (1) NZ259531A (en)
WO (1) WO1994015603A1 (en)
ZA (1) ZA9469B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8188126B2 (en) 2002-05-16 2012-05-29 Pierre Fabre Medicament Imidazolic compounds and use thereof as alpha-2 adrenergic receptors

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH16249A (en) * 1980-02-04 1983-08-16 Reckitt & Colmann Prod Ltd Imidazoline derivatives,its pharmaceutical composition and method of use
NZ199469A (en) * 1981-01-30 1984-03-16 Reckitt & Colmann Prod Ltd Benzodioxanyl-2-imidazoline derivatives and pharmaceutical compositions
NZ203680A (en) * 1982-04-17 1985-08-16 Reckitt & Colmann Prod Ltd Imidazolines and pharmaceutical compositions
GB2174087A (en) * 1985-04-23 1986-10-29 Glaxo Group Ltd Heterocyclic amino compounds
GB8903437D0 (en) * 1989-02-15 1989-04-05 Erba Carlo Spa Imidazolyl derivatives of 3,4-dihydro-2h-1-benzothiopyran

Also Published As

Publication number Publication date
ZA9469B (en) 1996-02-01
JPH08505154A (en) 1996-06-04
NZ259531A (en) 1997-04-24
FR2700113A1 (en) 1994-07-08
AU680463B2 (en) 1997-07-31
WO1994015603A1 (en) 1994-07-21
EP0678024A1 (en) 1995-10-25
CA2153399A1 (en) 1994-07-21
FR2700113B1 (en) 1995-03-24

Similar Documents

Publication Publication Date Title
AU673703B2 (en) Injector and use of the same
AU6566094A (en) Heterocyclic derivatives in the treatment of ischaemia and related diseases
AU5687896A (en) Use of alpha 1L-agonists in the treatment of incontinence
AU5590596A (en) Use of calpain inhibitors in the inhibition and treatment of neurodegeneration
AU3482495A (en) Substituted heteroaromatic compounds and their use in medicine
AU3959193A (en) Heterocyclic compounds and their use in the treatment of type II-diabetes
AU8154294A (en) Methods of inhibiting atrophy of the skin and vagina
AU4098393A (en) Laminate and use of the same
AU2466695A (en) The use of famotidine and related compounds in the treatment of movement disorders
AU3099997A (en) The use of tcet in the prophylaxis and treatment of allergies
AU6946594A (en) Methods for the treatment and prevention of diarrhea
AU3551993A (en) Tetraazacyclododecane derivative and its use
AU6983894A (en) Thiazolidine derivative and medicine containing the same
AU1908095A (en) The use of mannan-rich materials in feedstuffs
AU8427091A (en) Gamma-carboxylase and methods of use
AU4100593A (en) Iminoalcohol-oxazolidine mixtures and their use
AU4787593A (en) Heterocyclic derivatives useful in the treatment of cardiovascular diseases
AU4812393A (en) Use of rapamycin in the treatment of aids
AU2705495A (en) Use of rooperol and hypoxoside and their derivatives in the treatment of inflammatory
AU680463B2 (en) Use of idazoxan and its derivatives in the treatment of alzheimer-type senility
AU4319393A (en) Use of indolocarbazols in aids treatment
AU2905995A (en) Brefeldin A derivatives and their utility in the treatment of cancer
AU5975094A (en) 1,2,4-triazinone derivatives and their use in therapy
AU671860B2 (en) Use of furancarboxamides in the protection of materials
AU7399394A (en) Measuring bioimpedance values and treating mental disorders